MALIGNANT NEOPLASM OF THYMUS

MALIGNANT NEOPLASM OF THYMUS was reported 49 times

MALIGNANT NEOPLASM OF THYMUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Provitamin D2 Compound [EPC] 2 0.0001
2 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
3 Prostaglandin Analog [EPC] 3 0.0000
4 Angiotensin Converting Enzyme Inhibitor [EPC] 4 0.0000
5 Interleukin-17A Antagonist [EPC] 1 0.0000
6 beta3-Adrenergic Agonist [EPC] 1 0.0000
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
8 Factor Xa Inhibitor [EPC] 5 0.0000
9 Aromatase Inhibitor [EPC] 2 0.0000
10 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
11 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
12 Kinase Inhibitor [EPC] 6 0.0000
13 Aminosalicylate [EPC] 1 0.0000
14 Proteasome Inhibitor [EPC] 1 0.0000
15 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
16 Proton Pump Inhibitor [EPC] 5 0.0000
17 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
18 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
19 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
20 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
21 Calcium [EPC] 1 0.0000
22 Microtubule Inhibitor [EPC] 1 0.0000
23 Interferon beta [EPC] 1 0.0000
24 RANK Ligand Inhibitor [EPC] 1 0.0000
25 Corticosteroid [EPC] 6 0.0000
26 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
27 Vitamin D [EPC] 1 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
29 Vitamin B12 [EPC] 1 0.0000
30 Vitamin C [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
32 Thalidomide Analog [EPC] 1 0.0000
33 Platelet Aggregation Inhibitor [EPC] 1 0.0000
34 Benzodiazepine [EPC] 1 0.0000